- Mr. Meleveetil Damodaran has completed his second and final term as an Independent Director at Biocon Limited.
- His tenure ended at the close of business hours on July 25, 2024.
Unlock the Full Filing And Lot More
Access premium insights and stay ahead of the market with Dzambhala Pro.
Learn MoreBIOCON PRIOR FILINGS
- 11h ago
- 1d ago
- 2d ago
- 2d ago
- 6d ago
Biocon Biologics To Highlight Expanding Product Pipeline At J.P. Morgan Healthcare Conference
Biocon Engages Institutional Investor Quest Investment Advisors in Virtual Meeting, No UPSI Disclos…
Biocon Biologics Marks One Year as Global Biosimilars Leader, Surpassing $1 Billion in Revenue and …
Biocon Gets Approval for Ustekinumab BS Biosimilar in Japan, Expanding Global Presence
Biocon To Hold Q3 FY 2024-25 Earnings Call on January 31, Trading Window Closed Until February 1
ALL LATEST FILINGS
- 7h ago
- 7h ago
- 8h ago
- 8h ago
- 9h ago
Britannia Faces ₹105 Cr GST Tax Demand Over Kulcha Classification Issues
IRB Infrastructure Reports 19% Growth in Toll Revenue to ₹580 Cr for December 2024
NTPC Signs Supplementary Joint Venture Agreement with NPCIL, Restructures ASHVINI Shareholding to 5…
Lemon Tree Hotels Faces ₹1 Lac Partial Forfeiture of Bank Guarantee Over Pollution Non-Compliance
TCS Reports Q3 FY25 Earnings With Standalone And Consolidated Results Approved By Board